3rd Circ. Reiterates ERISA Allows 'Catalyst Theory' Fees
The Third Circuit refused Monday to reconsider its decision that hemophiliacs and pharmacies who sued insurers that denied their claims for blood-clotting medications are eligible for $350,000 in attorneys' fees because...To view the full article, register now.
Already a subscriber? Click here to view full article